126 related articles for article (PubMed ID: 8781908)
1. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in dysplasia in inflammatory bowel disease.
Kullmann F; Fadaie M; Gross V; Knüchel R; Bocker T; Steinbach P; Schölmerich J; Rüschoff J
Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):371-9. PubMed ID: 8781908
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of proliferative Ki-67 nuclear antigen is correlated with dysplastic colorectal epithelium in ulcerative colitis.
Sjöqvist U; Ost A; Löfberg R
Int J Colorectal Dis; 1999 Apr; 14(2):107-13. PubMed ID: 10367256
[TBL] [Abstract][Full Text] [Related]
3. The use of proliferating cell nuclear antigen (PCNA) expression and intraepithelial lymphocyte count in the differential diagnosis of inflammatory bowel disease.
Keller K; Koch HK
Ital J Gastroenterol; 1994 Jun; 26(5):233-7. PubMed ID: 7919464
[TBL] [Abstract][Full Text] [Related]
4. Differences in cell proliferation and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinomas of the extrahepatic biliary tract.
Lee CS
Cancer; 1996 Nov; 78(9):1881-7. PubMed ID: 8909306
[TBL] [Abstract][Full Text] [Related]
5. A comparison of proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell position in the crypts of normal human colonic mucosa.
Bromley M; Rew D; Becciolini A; Balzi M; Chadwick C; Hewitt D; Li YQ; Potten CS
Eur J Histochem; 1996; 40(2):89-100. PubMed ID: 8839702
[TBL] [Abstract][Full Text] [Related]
6. Analysis of proliferative activity in colorectal mucosa by immunohistochemical detection of proliferating cell nuclear antigen (PCNA). Methodological aspects and application to routine diagnostic material.
Diebold J; Lai MD; Löhrs U
Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(5):283-9. PubMed ID: 1359701
[TBL] [Abstract][Full Text] [Related]
7. Computer-assisted quantitative analysis of Ki-67 antigen in dysplasia--associated lesions or masses in ulcerative colitis.
Zivković V; Petrović A; Dordević B; Katić V; Gligorijević J; Pavlović V; Krstić M
Vojnosanit Pregl; 2007 Nov; 64(11):753-8. PubMed ID: 18050970
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.
Bozlu M; Orhan D; Baltaci S; Yaman O; Elhan AH; Tulunay O; Müftüoğlu YZ
Int Urol Nephrol; 2002; 33(1):59-66. PubMed ID: 12090340
[TBL] [Abstract][Full Text] [Related]
9. Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study.
Tiniakos DG; Brunt EM
Liver; 1999 Feb; 19(1):58-68. PubMed ID: 9928768
[TBL] [Abstract][Full Text] [Related]
10. High proliferative activity is associated with dysplasia in ulcerative colitis.
Shinozaki M; Watanabe T; Kubota Y; Sawada T; Nagawa H; Muto T
Dis Colon Rectum; 2000 Oct; 43(10 Suppl):S34-9. PubMed ID: 11052476
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical detection of cell-cycle associated markers on paraffin embedded and formalin fixed needle biopsies of prostate cancer: correlation of p120 protein expression with AgNOR, PCNA/cyclin, Ki-67/MIB1 proliferation-scores and Gleason gradings.
Botticelli AR; Casali AM; Botticelli L; Zaffe D
Eur J Histochem; 1998; 42(1):41-8. PubMed ID: 9615190
[TBL] [Abstract][Full Text] [Related]
12. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus.
Hong MK; Laskin WB; Herman BE; Johnston MH; Vargo JJ; Steinberg SM; Allegra CJ; Johnston PG
Cancer; 1995 Jan; 75(2):423-9. PubMed ID: 7812911
[TBL] [Abstract][Full Text] [Related]
13. Ki-67: a useful marker for the evaluation of dysplasia in ulcerative colitis.
Andersen SN; Rognum TO; Bakka A; Clausen OP
Mol Pathol; 1998 Dec; 51(6):327-32. PubMed ID: 10193513
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry in the diagnosis of dysplasia in chronic inflammatory bowel disease colorectal polyps.
B Brahim E; Mrabet A; Jouini R; Koubaa W; B Sidhom R; Elloumi H; Chadli A
Arab J Gastroenterol; 2016 Sep; 17(3):121-126. PubMed ID: 27567189
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of Ki-67 and PCNA in canine mammary tumors: relationship to clinical and pathologic variables.
Peña LL; Nieto AI; Pérez-Alenza D; Cuesta P; Castaño M
J Vet Diagn Invest; 1998 Jul; 10(3):237-46. PubMed ID: 9683072
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen (PCNA) and Ki-67 immunopositivity in human astrocytic tumours.
Kordek R; Biernat W; Alwasiak J; Liberski PP
Acta Neurochir (Wien); 1996; 138(5):509-12; discussion 513. PubMed ID: 8800324
[TBL] [Abstract][Full Text] [Related]
18. Is Ki-67 a better proliferative marker in the colon than proliferating cell nuclear antigen?
Holt PR; Moss SF; Kapetanakis AM; Petrotos A; Wang S
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):131-5. PubMed ID: 9037564
[TBL] [Abstract][Full Text] [Related]
19. Expression of p53, bcl-2, and Ki-67 proteins in the inflammatory regenerative and dysplastic epithelial lesions of flat colonic mucosa.
Radović S; Vukobrat-Bijedić Z; Selak I; Babić M
Bosn J Basic Med Sci; 2006 Feb; 6(1):39-45. PubMed ID: 16533178
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies on the biological significance of the marker for proliferation Ki-67-Antigen and PCNA in primary ovarian carcinoma].
Reitmaier M; Rudlowski C; Biesterfeld S; Rath W; Schröder W
Zentralbl Gynakol; 2000; 122(7):361-7. PubMed ID: 10951706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
